-
Clinical trial tests therapy for aggressive B-cell lymphomas
-
Tumor cells in transparent fish reveal factors that determine metastasis sites
-
FDA grants breakthrough therapy designation of new TIL therapy for advanced cervical cancer
-
In patients with severe chronic lymphocytic leukemia, B cells get stuck in hyperactive mode
-
Landmark discovery: H2AX as a sensor of DNA damage
-
New #ClinicalTrial of combination therapy for aggressive B-cell #lymphoma being led by @RoschewskiMD… https://t.co/tKVG37ONiL
-
RT @IRPatNIH: The #NIH IRP has a long track record of producing innovations to help improve #flu care and prevention. We recently… https://t.co/eiqVJzOUa1
-
#ThrowbackThursday photo of our 1991 Clinical Care Staff - see any familiar faces?!! @NIHClinicalCntr @theNCI https://t.co/BRUFHOxdFR
-
#CCRAdvance A research team led by @Tanner_Lab watches human cancer cells travel through the bodies of zebrafish, l… https://t.co/0rBFnR5Kf8
-
RT @theNCI: Do you have a friend or loved one with questions about cancer? NCI’s Cancer Information Service provides clear and… https://t.co/b80s36B3XV
-
RT @Dr_RaviMadan: We welcome @ramya_ramaswami to @NCI's Clinical Investigator Development Program (#CIDP) for #cancer researchers Le… https://t.co/em18JEDSvp
-
Latest #CCRAdvance from Tosato et al. provides novel insights into endothelial cell contact inhibition of growth an… https://t.co/WVakdK2UdB
